K102499 is an FDA 510(k) clearance for the DUOFERTILITY. Classified as Device, Fertility Diagnostic, Proceptive (product code LHD).
Submitted by Cambridge Temperature Concepts , Ltd. (Cambridge, US). The FDA issued a Cleared decision on December 20, 2011 after a review of 476 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Obstetrics & Gynecology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.
NCT01343199
Completed
Observational
Comparison of DuoFertility, LadyComp/BabyComp and Clearblue Monitors
Pilot Study Comparing Fertility Monitors: DuoFertility Monitor, LadyComp/Babycomp Monitor and Clearblue Ovulation Tests in Support of FDA Application
| Condition studied |
Infertility |
| Eligibility |
Female only
· 18 Years+
· Healthy volunteers accepted
|
| Principal investigator |
Basil Matta |
| Sponsor |
Cambridge University Hospitals NHS Foundation Trust
|
Started 2011-03-01
→
Primary completion 2014-05-01
Study completed - no results published.
This trial concluded in 2014 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov